Publish with Us Search
Publish with Us

Molecular Modeling Connect

ISSN: 3006-9084

Robert Vianello
Editor-in-Chief

Robert Vianello
Editor-in-Chief

View Profile

Molecular Modeling Connect is a dynamic, peer-reviewed, open-access journal dedicated to advancing the frontiers of molecular modeling and simulation. Published biannually in both print and online formats, the journal provides a platform for cutting-edge research in a wide range of topics related to molecular modeling and simulation.

Volumes 2
Articles 11
Volume: 2, 2025
Submit Article Join Our Editorial Board Become a Reviewer
Download Flyer
Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Open Access Policy:
All articles published in the journal “Molecular Modeling Connect” are made accessible through an open-access model, released under the CCBY license. This license facilitates the unrestricted dissemination of articles, encouraging widespread sharing and utilization of valuable research contributions.

Publication Charges:
There will be no article processing charges (APCs) for submissions made by December 2025, and all articles will be available as Open Access.

Subject Categories:
Chemistry, Molecular Modelling, Drug Discovery, Computational Biology

Article Template:
You are encouraged to use the template to format your article according to our guidelines. However, this is not mandatory, as our layout team will ensure all necessary adjustments are made after acceptance and prior to final publication.

Download Template

Target Audience:
Molecular Modeling Connect is tailored for researchers, academics, industry professionals, and practitioners immersed in the dynamic realms of molecular modeling and simulation, spanning across disciplines such as chemistry, biochemistry, materials science, drug discovery, and computational biology.

Ethics Statement:

All articles published by Molecular Modeling Connect adhere strictly to the ethical guidelines suggested by the Committee on Publication Ethics (COPE).  We execute a stringent peer-review procedure that meticulously assesses the originality, quality, and precision of the research we disseminate. We employ advanced tools to scrutinize the legitimacy of submitted content and maintain a firm zero-tolerance stance toward instances of plagiarism, data manipulation, or inappropriate authorship.
For further details, please review our comprehensive Publication Ethics and Integrity Guidelines.

Insights

More Insights

35 Days

Time to First Peer Review Decision

112 Days

Time to Final Acceptance

1 Day

Acceptance to First Online

Recent Updates

All Updates
Transition in Editorial Leadership – Molecular Modeling Connect
2025-07-01
Molecular Modeling Connect welcomes Vannajan Sanghiran Lee as Editor-in-Chief
2024-03-14
Scifiniti launches new open access journal, Molecular Modeling Connect
2024-03-10

Recent Articles

All Articles
Research Article

Published: 25 Jul 2025

Structural and Molecular Changes of Isonicotinylhydrazine Anti-Tubercular Drug in Alcohol Environment: An Intuition from Theory

Volume 2

https://doi.org/10.69709/MolModC.2025.112309
Research Article

Published: 27 Jun 2025

The Impact of Toxic Effector Molecule TagX on the Amino Acid Conformation of the Hcp1 Monohexameric Ring in Acinetobacter baumannii Type VI Secretion System Utilizing Bioinformatics Tools and an AI System

Volume 2

Limited information is currently available regarding the contraction mechanism of the Hcp-1 hemolysin-coregulated protein within the type VI secretion system (T6SS) of Acinetobacter baumannii, particularly about the secretion of toxic effectors. This research aimed to evaluate the mechanism underlying the contraction of the Hcp1 nanotube in response to the putative toxic effector TagX protein by employing bioinformatics tools and the..

https://doi.org/10.69709/MolModC.2025.102135
Editorial

Published: 07 Jul 2025

The Predictive Revolution: Rethinking Science Through Molecular Modeling

Volume 2

https://doi.org/10.69709/MolModC.2025.132344
Research Article

Published: 07 May 2025

Exploring Artesunate and Dihydroartemisinin for Mechanism on MMP-3 and MMP-13 via Molecular Docking and Molecular Dynamics

Volume 2

The application of natural products has drawn increasing attention in recent times. Artesunate (ART) and Dihydroartemisinin (DHA), being natural products with anti-inflammatory and cartilage protective capabilities, have shown potential in osteoarthritis (OA) treatment. OA is a highly prevalent degenerative joint disease globally, leading to a diminished quality of life and is a major cause of disability. Matrix metalloproteinase 3 (MMP-3)..

https://doi.org/10.69709/MolModC.2025.142325
Share
Help